BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Celldex Therapeutics, Inc. (CLDX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Celldex Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-11
4:33 pm
Sale		 2020-12-31 13G Celldex Therapeutics, Inc.
CLDX		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -2,740,000decrease
(Position Closed)		 Filing
2020-06-26
5:28 pm
Purchase		 2020-06-16 13G Celldex Therapeutics, Inc.
CLDX		 BIOTECHNOLOGY VALUE FUND L P 2,740,000
7.200%		 2,740,000increase
(New Position)		 Filing